GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Price-to-Operating-Cash-Flow

China Isotope & Radiation (HKSE:01763) Price-to-Operating-Cash-Flow : 37.32 (As of May. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Price-to-Operating-Cash-Flow?

As of today (2024-05-24), China Isotope & Radiation's share price is HK$10.86. China Isotope & Radiation's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.29. Hence, China Isotope & Radiation's Price-to-Operating-Cash-Flow Ratio for today is 37.32.

The historical rank and industry rank for China Isotope & Radiation's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:01763' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.04   Med: 8.24   Max: 43.71
Current: 37

During the past 9 years, China Isotope & Radiation's highest Price-to-Operating-Cash-Flow Ratio was 43.71. The lowest was 4.04. And the median was 8.24.

HKSE:01763's Price-to-Operating-Cash-Flow is ranked worse than
74.26% of 439 companies
in the Medical Devices & Instruments industry
Industry Median: 20.88 vs HKSE:01763: 37.00

China Isotope & Radiation's Cash Flow from Operations per share for the six months ended in Dec. 2023 was HK$1.29. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.29.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of China Isotope & Radiation was -90.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -35.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -21.10% per year.

During the past 9 years, China Isotope & Radiation's highest 3-Year average Operating Cash Flow per Share Growth Rate was 17.00% per year. The lowest was -35.50% per year. And the median was 9.20% per year.


China Isotope & Radiation Price-to-Operating-Cash-Flow Historical Data

The historical data trend for China Isotope & Radiation's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation Price-to-Operating-Cash-Flow Chart

China Isotope & Radiation Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only 10.05 24.49 7.23 4.44 45.91

China Isotope & Radiation Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.23 - 4.44 - 45.91

Competitive Comparison of China Isotope & Radiation's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, China Isotope & Radiation's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Isotope & Radiation's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's Price-to-Operating-Cash-Flow falls into.



China Isotope & Radiation Price-to-Operating-Cash-Flow Calculation

China Isotope & Radiation's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=10.86/0.291
=37.32

China Isotope & Radiation's Share Price of today is HK$10.86.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

China Isotope & Radiation Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation (HKSE:01763) Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Ubs Group Ag 2201 Interest of corporation controlled by you
Li Hongbo 2201 Interest of corporation controlled by you
Lianwen Ltd 2101 Beneficial owner
Invesco Advisers, Inc. 2102 Investment manager
The Bank Of New York Mellon Corporation 2201 Interest of corporation controlled by you
Invesco Hong Kong Limited 2102 Investment manager
Invesco Corporate Class Inc. 2106 Person having a security interest in shares
M&g Plc 2201 Interest of corporation controlled by you
Shanghai Industrial Holdings Limited 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Serenity Investment Master Fund Limited 2101 Beneficial owner
Serenity Capital Management, Ltd. 2102 Investment manager
Shanghai Pharmaceuticals Holding Co., Ltd. 2201 Interest of corporation controlled by you
S.i. Infrastructure Holdings Limited 2201 Interest of corporation controlled by you

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines